Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
3 participants
INTERVENTIONAL
2014-09-30
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease
NCT00013923
Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol
NCT02260167
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
NCT02791191
A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease
NCT02431468
A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
NCT02614131
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment with d-ribose
Treatment with ribose 5 gm TID
d-ribose
giving ribose in those with a diagnosis of Alzheimer's and/or dementia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
d-ribose
giving ribose in those with a diagnosis of Alzheimer's and/or dementia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must have a caregiver living with them.
Exclusion Criteria
* Also, severe life threatening illnesses which would make them unlikely to be alive after 6-12 months.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Practitioners Alliance Network
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PAN
Kailua, Hawaii, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PAN- ALZ001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.